In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...